EP4 receptor activation in a murine model of Alzheimer's disease, EP4 deficiency or the EP4 antagonist ONO-AE3-208 decreased amyloid-β levels in the brain and improved the behavioral performance of the animals (Hoshino et al., 2012). This evidence concerns the gene PTGER4 and early-onset autosomal dominant Alzheimer disease.